Medicine for treating esophageal cancer

Abstract

The invention relates to a medicine for treating esophageal cancer. China has high esophageal cancer rate, the number of people died from esophagus cancer is only second to that of people died from stomach cancer. At present, esophagus cancer is mainly treated by radiotherapy and chemotherapy, which have serious side effects. The medicine is prepared from dry powder of extracts of indigowoad root, euphorbia lunulata, artificial bezoar, sal ammoniac and clematis chineniss osbeck. The root of the pathomechanism of esophageal cancer lies in that the functions of the body decades due to weak Yang qi. Esophageal cancer is mainly treated by warming Yang, tonifying qi, strengthening vital energy and improving body functions. The treatment principle of traditional Chinese medicine is demonstrated in the invention. The medicine is capable of soothing liver, regulating qi, descending adverse qi, removing stasis, promoting blood circulation, removing stasis, softening hardness to dissipate stagnation, strengthening body resistance and archaeus, promoting the secretion of saliva or body fluid, moistening dryness, resolving phlegm, clearing heat, detoxifying, resisting cancer, relieving pain, warming Yang, tonifying qi and the like. Compared with other method for treating esophageal cancer, the medicine is relatively guaranteed and safe and has the advantages of stable dose and component, convenience for oral administration, and obvious treatment effect.

Description

technical field [0001] The invention relates to a medicine for treating esophageal cancer. Background technique [0002] Esophageal cancer is a malignant tumor that occurs in the esophageal epithelium, accounting for 2% of all malignant tumors. About 220,000 people die from esophageal cancer every year in the world. my country is an area with a high incidence of esophageal cancer. The number of deaths due to esophageal cancer is second only to gastric cancer. The existing treatments are mainly radiotherapy and chemotherapy, which have serious side effects. [0003] purpose of invention [0004] Aiming at the above-mentioned shortcomings, the present invention provides a drug for treating esophageal cancer that is relatively guaranteed and safe, has stable dosage components, is convenient to take, and has convenient curative effect. Contents of the invention [0005] In order to achieve the above object, the present invention adopts the following technical solutions (by w...

AI Technical Summary

Problems solved by technology

About 220,000 people die from esophageal cancer every year in the world. my country is an area with a high incidence of esophageal cancer. The number of deaths due to esophageal cancer is second only to gastric cancer. The existing treatments are mainly radiotherapy and chemotherapy, which have many side effects